Empower Your Fight Against Colorectal Cancer
Colorectal cancer demands a clear roadmap and comprehensive strategy. Dive deeply into the mechanism of the illness, current treatments, and how securely retaining your living tumor tissues can unlock cutting-edge functional and molecular diagnostic options.
Talk to a Care SpecialistWhat is Colorectal Cancer?
Colorectal cancer starts in the colon or the rectum, which are the parts making up the large intestine. Depending on where it begins, it may specifically be called colon cancer or rectal cancer.
Most of these cancers start as a growth on the inner lining of the colon or rectum, known as a polyp. While some polyps are benign, certain types (adenomas) can transform into cancer over the course of several years. When caught early, standard interventions are effective, but advanced stages demand complex therapies.
What Does Colorectal Cancer Do?
As the tumor develops, it invades the wall of the colon or rectum, often disrupting normal digestive function, before spreading to adjacent lymph nodes or distant organs.
- Bowel Interference: Tumors can create blockages resulting in persistent changes to bowel habits, severe cramping, and weakness.
- Vascular Invasion: Expanding tumors can establish their own blood supply, leading to bleeding into the digestive tract and resulting anemia.
- Distant Metastasis: If unchecked, colorectal cancer frequently spreads via the bloodstream to organs like the liver or lungs.
Current Treatment Options
Colectomy
The standard surgical removal of the portion of the colon or rectum containing the cancer, alongside nearby lymph nodes.
Targeted Drug Therapy
For advanced cancers possessing certain genetic markers (like EGFR), targeted therapies look to pinpoint specific abnormalities blocking cancer growth.
Pre-Operative Chemoradiation
Specifically heavily utilized in rectal cancer, combinations of radiation and chemotherapy are administered to aggressively shrink the tumor prior to surgical resection.
Why Bank Your Living Colorectal Tissue?
Colorectal cancer is highly mutated, meaning what treats one colon tumor might completely fail another. If you let the hospital destroy your tissue after surgery, doctors rely on broad estimations if the cancer returns. Cryopreserving your tissue enables direct verification.
Functional Drug Testing
Live tissue enables doctors to test multiple chemotherapies (like FOLFOX) and emerging targeted regimens directly on your tumor cells before putting them into your body.
Advanced Testing Models
Banked living tissues permit researchers to generate 3D organoid structures, creating an actionable physical replica of your lower digestive cancer biology.
Clinical Trial Readiness
Retaining your cellular architecture proves crucial for immediate entry into revolutionary clinical trials focusing on rare or unique colorectal mutations.
Future-Proofing Your Care
Diagnostic technologies mapped today can unlock precision therapies years from now. Keeping alive biological samples secures your access to these upcoming breakthroughs.